These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22137731)

  • 1. Management of proteinuria in clinical practice after kidney transplantation.
    Ruiz JC; Sánchez-Fructuoso A; Zárraga S
    Transplant Rev (Orlando); 2012 Jan; 26(1):36-43. PubMed ID: 22137731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management.
    Knoll GA
    Am J Kidney Dis; 2009 Dec; 54(6):1131-44. PubMed ID: 19726115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplantation proteinuria: an approach to diagnosis and management.
    Shamseddin MK; Knoll GA
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1786-93. PubMed ID: 21734095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New options and perspectives for proteinuria management after kidney transplantation.
    Soler MJ; Riera M; Gutierrez A; Pascual J
    Transplant Rev (Orlando); 2012 Jan; 26(1):44-52. PubMed ID: 22137732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and Management of Proteinuria After Kidney Transplantation.
    Tsampalieros A; Knoll GA
    Transplantation; 2015 Oct; 99(10):2049-60. PubMed ID: 26335919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of spironolactone to dual blockade of renin angiotensin system dramatically reduces severe proteinuria in renal transplant patients: an uncontrolled pilot study at 6 months.
    González Monte E; Andrés A; Polanco N; Toribio MJ; Santana R; Gutiérrez Martínez E; González J; Ramírez E; Hernández A; Morales E; Praga M; Morales JM
    Transplant Proc; 2010 Oct; 42(8):2899-901. PubMed ID: 20970564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade proteinuria and microalbuminuria in renal transplantation.
    Halimi JM
    Transplantation; 2013 Jul; 96(2):121-30. PubMed ID: 23435457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance and management of proteinuria in kidney transplant recipients.
    Amer H; Cosio FG
    J Am Soc Nephrol; 2009 Dec; 20(12):2490-2. PubMed ID: 19820126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation.
    Jennings DL; Taber DJ
    Ann Pharmacother; 2008 Jan; 42(1):116-20. PubMed ID: 18094340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation.
    Fernández-Fresnedo G; Plaza JJ; Sánchez-Plumed J; Sanz-Guajardo A; Palomar-Fontanet R; Arias M
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii47-51. PubMed ID: 15192136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late failure or human renal transplants. An analysis of transplant disease and graft failure among 125 recipients surviving for one to eight years.
    Petersen VP; Olsen TS; Kissmeyer-Nielsen F; Bohman SO; Hansen HE; Hansen ES; Skov PE; Solling K
    Medicine (Baltimore); 1975 Jan; 54(1):45-71. PubMed ID: 235063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progression factors in chronic kidney disease. Non-immunological mechanisms].
    Fernández Fresnedo G; Sánchez Plumed J; Arias M; Del Castillo Caba D; López Oliva MO
    Nefrologia; 2009; 29 Suppl 1():16-24. PubMed ID: 19675657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in proteinuria >200 mg/g after late rejection is associated with poor graft survival.
    Djamali A; Samaniego M; Torrealba J; Pirsch J; Muth BL
    Nephrol Dial Transplant; 2010 Apr; 25(4):1300-6. PubMed ID: 19934095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
    Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
    Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes and consequences of proteinuria following kidney transplantation.
    Suárez Fernández ML; G-Cosío F
    Nefrologia; 2011; 31(4):404-14. PubMed ID: 21738244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinuria after kidney transplantation.
    Ponticelli C; Graziani G
    Transpl Int; 2012 Sep; 25(9):909-17. PubMed ID: 22616794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance and diagnosis of proteinuria in renal transplantation.
    Calabuig AS; Guirado L; Ramos D
    Transplant Rev (Orlando); 2012 Jan; 26(1):30-5. PubMed ID: 22137730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histology and proteinuria after renal transplantation.
    Serón D; Burgos D; Alonso A
    Transplant Rev (Orlando); 2012 Jan; 26(1):20-6. PubMed ID: 22137728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuria after conversion to sirolimus in kidney transplant recipients: impact of pre-existing proteinuria, graft function, and angiotensin-converting enzyme inhibitors/angiotensin-receptor antagonists.
    Marx C; Busch M; Ott U; Gerth J; Wolf G
    Clin Transplant; 2010; 24(5):626-30. PubMed ID: 19925471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.